戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 gnificantly contributes to complications and device failure.
2 often hampered by specific complications and device failure.
3 aortic arch appear to be predictive of early device failure.
4 ic morphology was analyzed for predictors of device failure.
5 y malfunctions were the most common cause of device failure.
6 device malfunction and the likely effects of device failure.
7 most common reason for catheter exchange was device failure.
8 adation of cell membranes and thus premature device failure.
9 sulting in sensor performance compromise and device failure.
10 evolution of conduction channel and eventual device failure.
11 ons [27.1%]) accounted for half of the total device failures.
12 q(3) as well as for crystallization-assisted device failures.
13 nufacturers in identifying potentially fatal device failures.
14 ed toxicity (12 pts., 17%), and irreversible device failure (5 pts., 7%).
15  may be associated with a lower incidence of device failure and infection, but with more thromboembol
16 gher rate of complications, higher chance of device failure, and worse visual outcomes than observed
17  logistic regression identified only closure device failure as an independent predictor of a vascular
18 probability of survival free from stroke and device failure at 2 years as compared with a pulsatile d
19                                     However, device failure can occur gradually and start months afte
20                                              Device failure from diffusion short circuits in microele
21 xpected increases resulting from respiratory device failures in community-based patients.
22                                        Early device failure is associated with sharp angulation of th
23                                  Respiratory device failure (mechanical ventilators, positive pressur
24  examine the life expectancy, breakdown, and device failure of engineered skeletal muscle bio-bots as
25 evice failure rate and the likely effects of device failure on mortality.
26 welve late deaths have occurred, none due to device failure or AAA rupture.
27                            There has been no device failure or hemolysis.
28                           There were no late device failures or complications.
29 epends primarily on the advisory's estimated device failure rate and the likely effects of device fai
30  to a low, but potentially life-threatening, device failure rate found during postoperative testing.
31   For pacemaker-dependent patients, advisory device failure rates exceeding 0.3% warrant device repla
32 in the study group had device malfunction or device failure requiring replacement (16.2% vs. 8.8%), a
33 ing contacts leads to energy dissipation and device failure, resulting in massive economic and enviro
34 ients with ICDs, SD directly attributable to device failure seems to be rare.
35 fibrillator (ICD) shocks are associated with device failure, significant morbidity, and increased mor
36                                Infection and device failure still limit the safety of long periods of
37 undesirable thermal runaway effects and even device failure through self-heating.
38 minutes [IQR, 1.0-2.0]; P <.001) and closure device failure was also significantly lower among those

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。